X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

December 11, 2018

Container Closure Integrity at Low Temperatures

With the help of the FDA’s expedited programs for approval, a new wave of high-value biologic drugs is on the rise in the pharma industry.1 These drugs require cryogenic storage (-80oC to -180oC) to maintain stability. This presents a new challenge: how to measure and demonstrate container closure integrity (CCI) of storage and delivery systems at such low temperatures.<br />
West Pharma

Amy Kim

Specialist, Scientific Communications, TCS

Previous Posts
The Knowledge Center

March 27, 2018

Seeking Industry Insight? West Expands Online Knowledge Center

Deirdre Swinden

Deirdre Swinden

Director, Marketing Communications

DAIKYO PLASCAP

March 19, 2018

West to Distribute DAIKYO PLASCAP® RUV One-Step Press-Fit Vial Closure Solution

Deirdre Swinden

Deirdre Swinden

Director, Marketing Communications

Load more